kynurenic acid has been researched along with Central Nervous System Disease in 4 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Costantino, G | 1 |
Lu, H | 1 |
Kopcho, L | 1 |
Ghosh, K | 1 |
Witmer, M | 1 |
Parker, M | 1 |
Gupta, S | 1 |
Paul, M | 1 |
Krishnamurthy, P | 1 |
Laksmaiah, B | 1 |
Xie, D | 1 |
Tredup, J | 1 |
Zhang, L | 1 |
Abell, LM | 1 |
Linkswiler, H | 1 |
Wardley-Smith, B | 1 |
Halsey, MJ | 1 |
Hawley, D | 1 |
Joseph, MH | 1 |
4 other studies available for kynurenic acid and Central Nervous System Disease
Article | Year |
---|---|
Inhibitors of quinolinic acid synthesis: new weapons in the study of neuroinflammatory diseases.
Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; Central Nervous System Diseases; Enzyme Inhibitors; Humans; K | 2014 |
Development of a RapidFire mass spectrometry assay and a fluorescence assay for the discovery of kynurenine aminotransferase II inhibitors to treat central nervous system disorders.
Topics: Brain; Central Nervous System Diseases; Drug Evaluation, Preclinical; Enzyme Assays; Enzyme Inhibito | 2016 |
Biochemical and physiological changes in vitamin B6 deficiency.
Topics: Alanine Transaminase; Anemia, Hypochromic; Central Nervous System Diseases; Cysteine; Erythrocytes; | 1967 |
The effects of kynurenic acid, quinolinic acid and other metabolites of tryptophan on the development of the high pressure neurological syndrome in the rat.
Topics: Animals; Central Nervous System Diseases; High Pressure Neurological Syndrome; Kynurenic Acid; Male; | 1989 |